MedTrace Logo

Appropriate Prescribing for Older Adults With Multimorbidity (Pro-M)

NCT05756478 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2024-02-09

No results posted yet for this study

Summary

This is a two-site feasibility study to test implementation of an intervention that aims to reduce inappropriate prescribing for older adults with multimorbidity in geriatric medicine specialist clinics at public hospitals in Singapore. The specific aims are:

1. To assess the implementation outcomes: Appropriateness, Penetration/Reach, Acceptability, Feasibility, Sustainability (primary)
2. To collect data on recruitment and pre-post data on prevalence of potentially inappropriate prescribing (PIP) for the purpose of determining sample size for a scale up next phase study (secondary).
3. To conduct cost analysis of the intervention (secondary).

Conditions

  • Potentially Inappropriate Medications
  • Multimorbidity
  • Polypharmacy

Interventions

OTHER

Medication review

This is a feasibility study of implementing a pharmacist-led medication review using prescribing tools (e.g. STOPP/START, Beers Criteria)

Sponsors & Collaborators

  • Tan Tock Seng Hospital

    collaborator OTHER

  • Changi General Hospital

    collaborator OTHER

  • Geriatric Education and Research Institute

    lead OTHER_GOV

Principal Investigators

  • Penny Lun, M.A. · Geriatric Education and Research Institute, Singapore

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2023-10-16
Completion
2023-10-16

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05756478 on ClinicalTrials.gov